Chemistry: molecular biology and microbiology – Maintaining blood or sperm in a physiologically active state...
Reexamination Certificate
2007-02-27
2007-02-27
Saucier, Sandra (Department: 1651)
Chemistry: molecular biology and microbiology
Maintaining blood or sperm in a physiologically active state...
Reexamination Certificate
active
10423200
ABSTRACT:
The methods of this invention involve preventing the formation of a complex between adenine and riboflavin by reducing the amount of adenine in a solution containing blood or blood components to be pathogen reduced.
REFERENCES:
patent: 3629071 (1971-12-01), Sekhar
patent: 3874384 (1975-04-01), Diendoerfer et al.
patent: 4061537 (1977-12-01), Seiler et al.
patent: 4112070 (1978-09-01), Harmening
patent: 4267269 (1981-05-01), Grode et al.
patent: 4321919 (1982-03-01), Edelson
patent: 4390619 (1983-06-01), Harmening-Pittiglio
patent: 4432750 (1984-02-01), Estep
patent: 4572899 (1986-02-01), Walker et al.
patent: 4585735 (1986-04-01), Meryman et al.
patent: 4609372 (1986-09-01), Carmen et al.
patent: 4626431 (1986-12-01), Batchelor et al.
patent: 4675185 (1987-06-01), Kandler et al.
patent: 4695460 (1987-09-01), Holme
patent: 4704352 (1987-11-01), Miripol et al.
patent: 4769318 (1988-09-01), Hamasaki et al.
patent: RE32874 (1989-02-01), Rock et al.
patent: 4828976 (1989-05-01), Murphy
patent: 4925665 (1990-05-01), Murphy
patent: 4961928 (1990-10-01), Holme et al.
patent: 4992363 (1991-02-01), Murphy
patent: 4999375 (1991-03-01), Bachynsky et al.
patent: 5234808 (1993-08-01), Murphy
patent: 5250303 (1993-10-01), Meryman et al.
patent: 5344752 (1994-09-01), Murphy
patent: 5376524 (1994-12-01), Murphy et al.
patent: 5378601 (1995-01-01), Gepner-Puszkin
patent: 5459030 (1995-10-01), Lin et al.
patent: 5466573 (1995-11-01), Murphy et al.
patent: 5474891 (1995-12-01), Murphy
patent: 5487971 (1996-01-01), Holme et al.
patent: 5569579 (1996-10-01), Murphy
patent: 5622867 (1997-04-01), Livesey et al.
patent: 5709991 (1998-01-01), Lin et al.
patent: 5712085 (1998-01-01), Wollowitz et al.
patent: 5753428 (1998-05-01), Yuasa et al.
patent: 5769839 (1998-06-01), Carmen et al.
patent: 5827640 (1998-10-01), Wiggins et al.
patent: 5906915 (1999-05-01), Payrat et al.
patent: 5908742 (1999-06-01), Lin et al.
patent: 5955256 (1999-09-01), Sowemimo-Coker et al.
patent: 5955257 (1999-09-01), Burger et al.
patent: 5962213 (1999-10-01), Wiggins et al.
patent: 5965349 (1999-10-01), Lin et al.
patent: 6017691 (2000-01-01), Wollowitz et al.
patent: 6063624 (2000-05-01), Kandler et al.
patent: 6114107 (2000-09-01), Wiggins et al.
patent: 6251580 (2001-06-01), Lin et al.
patent: 6258577 (2001-07-01), Goodrich, Jr. et al.
patent: 6268120 (2001-07-01), Platz et al.
patent: 6277337 (2001-08-01), Goodrich, Jr. et al.
patent: 6277557 (2001-08-01), Burger et al.
patent: 6326197 (2001-12-01), Kandler et al.
patent: 6548241 (2003-04-01), McBurney et al.
patent: 6566046 (2003-05-01), Lin et al.
patent: 6936413 (2005-08-01), Bischof et al.
patent: 0754461 (1997-01-01), None
patent: WO85/02116 (1985-05-01), None
patent: WO92/08348 (1992-05-01), None
patent: WO92/08349 (1992-05-01), None
patent: WO94/16099 (1994-07-01), None
patent: WO96/14741 (1996-05-01), None
patent: WO98/41087 (1998-09-01), None
patent: WO98/56247 (1998-12-01), None
patent: WO00/04930 (2000-02-01), None
patent: WO00/11946 (2000-03-01), None
patent: WO01/45502 (2001-06-01), None
patent: WO01/78792 (2001-10-01), None
patent: WO01/94349 (2001-12-01), None
patent: WO01/96340 (2001-12-01), None
Yu et al. “Hypericin-Induced Phototoxicity in Cultured Fibroblasts and Swine Erythocytes”, Photochemistry and Photobiology, 64 (1) : 168-173 (1996).
Frati et al., “Degradation of hyaluronic acid by photosensitized riboflavin in vitro. Modulation of the effect by transition metals, radical quenchers, and metal chelators”, Free Radical Biology & Medicine 22 (7) : 1139-1144 (1997), abstract.
Balduini et al., “Cryopreservation of human platelets using dimethyl sulfoxide and glycerol-glucose: effects on “in vitro” platelet function”. Haematologica 78 (2) : 101-4 (1993), abstract.
Goodrich, R.P and Platz, M.S., “The design and development of selective, photoactivated drugs for sterilization of blood products,” 1997,Drugs of the Future22(2):159-171.
Uehara et al, “Effect of adenine on the riboflavin-sensitized photoreaction. II. Effect of adenine on the photodynamic inactivation of transforming deoxyribonucleic acid in the presence of riboflavin”, 1972,J Biochemistry. 71:5, 805-810.
Uehara et al, “Effect of adenine on the riboflavin-sensitized photoreaction. I. Effect of adenine on the photodynamic inactivation of yeast alcohol dehydrogenase in the presence of riboflavin,”J. Vitaminology, 17:3,1971,148-154.
Doane Suzann K.
Goodrich Raymond P.
Arciniegas Laura B.
Gambro Inc.
Merkling John R.
O'Connor Edna M.
Saucier Sandra
LandOfFree
Removal of adenine during a pathogen reduction process in... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Removal of adenine during a pathogen reduction process in..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Removal of adenine during a pathogen reduction process in... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3811070